Skip to content

Ferring: what changed

BE 0428.038.135NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€457,511
2024 · €407,922+€49,589
Equity
€3.1m
2024 · €2.6m+€457,512
Cash
€76,745
2024 · €77,368-€623
Balance sheet total
€11.0m
2024 · €7.7m+€3.3m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€7.2m

    up €7.2m (+208%), from €3.4m to €10.6m

    of which Trade receivables: +€6.3m

  • Stocks and contracts -€4.1m

    down €4.1m (-100%), from €4.1m to €0

  • Deferred charges and accrued income +€230,791

    up €230,791 (+659%), from €35,000 to €265,791

Equity and liabilities
  • Short-term financial debts +€2.0m

    up €2.0m (+96.9%), from €2.0m to €4.0m

  • Trade debts +€699,822

    up €699,822 (+36.2%), from €1.9m to €2.6m

  • Profit (loss) carried forward +€457,512

    up €457,512 (+20.1%), from €2.3m to €2.7m

  • Tax, wage and social debts +€148,749

    up €148,749 (+19.5%), from €762,831 to €911,580

    of which Remuneration and social security: +€86,739

Income statement
  • Other operating income +€5.0m

    up €5.0m (+1,602%), from €310,730 to €5.3m

  • Goods and materials +€3.4m

    up €3.4m (+25.4%), from €13.6m to €17.0m

    of which Change in stocks: decrease (increase): +€2.4m

  • Services and other goods +€897,530

    up €897,530 (+29.4%), from €3.0m to €3.9m

  • Staff costs +€219,448

    up €219,448 (+8.6%), from €2.5m to €2.8m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €407,922
Turnover -€23,627
Other operating income +€5.0m
Goods and materials -€3.4m
Services and other goods -€897,530
Staff costs -€219,448
Write-downs -€187,520
Other operating charges -€121,538
Other operating items +€1
Financial income -€1,007
Financial charges -€20,332
Taxes -€16,856
Result 2025 €457,511
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€2.0m
Investment +€0
Financing +€2.0m
Cash 2024 €77,368
Net result for the year +€457,511
Stocks and contracts +€4.1m
Receivables within one year -€7.2m
Deferred charges and accrued income -€230,791
Provisions +€72,405
Trade debts +€699,822
Tax, wage and social debts +€148,749
Accrued charges and deferred income -€25,924
Investment in fixed assets (net) +€0
Short-term financial debts +€2.0m
Contributions, distributions and other +€0
Cash 2025 €76,745
brings cash intakes cash out
Every line side by side 65 lines
Line Code 2024 2025 Change %
Total assets 20/58 €7,668,881 €10,976,015 +€3.3m +43.1%
Fixed assets 21/28 €11,633 €11,633 -€0 0.0%
Tangible fixed assets 22/27 €7,956 €7,956 -€0 0.0%
Other tangible fixed assets 26 €7,956 €7,956 -€0 0.0%
Financial fixed assets 28 €3,677 €3,677 = 0.0%
Other financial fixed assets 284/8 €3,677 €3,677 = 0.0%
Amounts receivable and cash guarantees 285/8 €3,677 €3,677 = 0.0%
Current assets 29/58 €7,657,249 €10,964,382 +€3.3m +43.2%
Stocks and contracts in progress 3 €4,100,578 €0 -€4.1m -100%
Stocks 30/36 €4,100,578 €0 -€4.1m -100%
Goods purchased for resale 34 €4,100,578 €0 -€4.1m -100%
Amounts receivable within one year 40/41 €3,444,303 €10,621,846 +€7.2m +208%
Trade receivables 40 €3,327,157 €9,601,971 +€6.3m +189%
Other amounts receivable 41 €117,145 €1,019,875 +€902,730 +771%
Cash at bank and in hand 54/58 €77,368 €76,745 -€623 -0.8%
Deferred charges and accrued income 490/1 €35,000 €265,791 +€230,791 +659%
Total equity and liabilities 10/49 €7,668,881 €10,976,015 +€3.3m +43.1%
Equity 10/15 €2,629,997 €3,087,509 +€457,512 +17.4%
Contributions 10/11 €322,500 €322,500 +€0 0.0%
Capital 10 €322,500 €322,500 +€0 0.0%
Issued capital 100 €322,500 €322,500 +€0 0.0%
Reserves 13 €32,250 €32,250 = 0.0%
Non-distributable reserves 130/1 €32,250 €32,250 = 0.0%
Legal reserve 130 €32,250 €32,250 = 0.0%
Profit (loss) carried forward 14 €2,275,247 €2,732,759 +€457,512 +20.1%
Provisions and deferred taxes 16 - €72,405 +€72,405
Provisions for liabilities and charges 160/5 - €72,405 +€72,405
Other liabilities and charges 164/5 - €72,405 +€72,405
Amounts payable 17/49 €5,038,884 €7,816,101 +€2.8m +55.1%
Amounts payable within one year 42/48 €4,715,643 €7,518,783 +€2.8m +59.4%
Financial debts 43 €2,017,278 €3,971,847 +€2.0m +96.9%
Credit institutions 430/8 €2,017,278 €3,971,847 +€2.0m +96.9%
Trade debts 44 €1,935,535 €2,635,357 +€699,822 +36.2%
Suppliers 440/4 €1,935,535 €2,635,357 +€699,822 +36.2%
Taxes, remuneration and social security 45 €762,831 €911,580 +€148,749 +19.5%
Taxes 450/3 €86,779 €148,789 +€62,010 +71.5%
Remuneration and social security 454/9 €676,052 €762,791 +€86,739 +12.8%
Accrued charges and deferred income 492/3 €323,241 €297,317 -€25,924 -8.0%
Operating income 70/76A €20,710,901 €25,663,985 +€5.0m +23.9%
Turnover 70 €20,400,171 €20,376,544 -€23,627 -0.1%
Other operating income 74 €310,730 €5,287,441 +€5.0m +1,602%
Operating charges 60/66A €20,087,785 €24,953,085 +€4.9m +24.2%
Goods for resale, raw materials and consumables 60 €13,550,455 €16,989,720 +€3.4m +25.4%
Purchases 600/8 €12,823,886 €13,865,502 +€1.0m +8.1%
Change in stocks: decrease (increase) 609 €726,569 €3,124,219 +€2.4m +330%
Services and other goods 61 €3,048,692 €3,946,222 +€897,530 +29.4%
Remuneration, social security and pensions 62 €2,539,231 €2,758,679 +€219,448 +8.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €0 - =
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€130,300 €57,220 +€187,520
Other operating charges 640/8 €1,079,706 €1,201,244 +€121,538 +11.3%
Operating profit (loss) 9901 €623,116 €710,900 +€87,784 +14.1%
Financial income 75/76B €1,007 €0 -€1,007 -100%
Recurring financial income 75 €1,007 €0 -€1,007 -100%
Income from current assets 751 €1,007 €0 -€1,007 -100%
Other financial income 752/9 €0 €0 =
Financial charges 65/66B €53,201 €73,533 +€20,332 +38.2%
Recurring financial charges 65 €53,201 €73,533 +€20,332 +38.2%
Debt charges 650 €49,018 €63,241 +€14,223 +29.0%
Other financial charges 652/9 €4,183 €10,292 +€6,109 +146%
Profit (loss) for the period before taxes 9903 €570,922 €637,367 +€66,445 +11.6%
Income taxes 67/77 €163,000 €179,856 +€16,856 +10.3%
Taxes 670/3 €163,000 €179,856 +€16,856 +10.3%
Tax adjustments and reversals of tax provisions 77 €0 - =
Profit (loss) for the period 9904 €407,922 €457,511 +€49,589 +12.2%
Profit (loss) for the period to be appropriated 9905 €407,922 €457,511 +€49,589 +12.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€3.3m to €4.1m

Midpoint €3.6m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €3.1m
Capitalised earnings €3.6m to €5.0m
Indication €3.3m to €4.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€3,087,509
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€3.1m

Capitalised earnings

net result for the year (9904)
2025
€457,511
2024
€407,922
2023
€649,371
2022
€533,990
2021
€848,870
Average result
€504,935
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€3.6m / €4.2m / €5.0m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.